Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
 
Register | Sign in
Home Page>Products
  Product News
GE Healthcare Life Sciences Launches illustra™ Single Cell GenomiPhi
Tuesday, September 02, 2014
Delivering high quality gDNA from a single cell.

BIOCRATES Announces Launch of Metabolomics-based Bile Acids Kit
Tuesday, September 02, 2014
Company further expands its range of metabolomics-based test kits with the addition of its assay for the quantitation of endogenous bile acids, allowing a panel of up to 19 analytes to be simultaneously quantitated from a single 10 µL sample.

Easy-to-use, Quantitative Gamma-H2AX Assay
Tuesday, September 02, 2014
Gamma H2AX pharmacodynamic assay kit for the study of double strand DNA breaks.

Versatile Range of Horizontal Gel Electrophoresis Units
Tuesday, September 02, 2014
Cleaver MultiSUB™ gel electrophoresis range for low- and high-throughput DNA and RNA applications.

New Eppendorf Advantage™ Offers
Tuesday, September 02, 2014
Users start their research with great sample prep from Eppendorf.

Protect Personnel from Chemical Vapors
Saturday, August 30, 2014
New Vent-Box ductless filtration system from Air Science.

Bosch Showcases Secondary Packaging Solutions
Friday, August 29, 2014
Strengthening position as single-source solutions provider.

Measure Both Elastic and Viscous Properties with AFM
Friday, August 29, 2014
Asylum Research’s exclusive AM-FM viscoelastic mapping mode.

Impressive Separation of a Fusion Protein
Friday, August 29, 2014
Separation of protein by high-resolution hydrophobic interaction chromatography method.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 10437
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv